Variant report

Variant	nsv833249
Chromosome Location	chr16:59282950-59461023
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr16:59390375-59391138	K562	blood:	n/a	n/a
2	ARID3A	chr16:59392455-59392495	K562	blood:	n/a	n/a
3	ATF1	chr16:59390559-59391019	K562	blood:	n/a	n/a
4	ATF1	chr16:59418654-59418858	K562	blood:	n/a	n/a
5	ATF3	chr16:59390611-59390910	K562	blood:	n/a	n/a
6	BACH1	chr16:59390770-59390783	K562	blood:	n/a	n/a
7	BACH1	chr16:59459499-59459576	K562	blood:	n/a	n/a
8	BCL3	chr16:59358233-59358843	A549	lung:	n/a	chr16:59358586-59358595
9	BHLHE40	chr16:59390614-59391020	K562	blood:	n/a	n/a
10	BRCA1	chr16:59383787-59383848	Hela-S3	cervix:	n/a	n/a
11	CBX3	chr16:59390599-59391070	K562	blood:	n/a	n/a
12	CCNT2	chr16:59390339-59391032	K562	blood:	n/a	n/a
13	CEBPB	chr16:59410393-59410398	HepG2	liver:	n/a	n/a
14	CEBPB	chr16:59361873-59362174	A549	lung:	n/a	n/a
15	CEBPB	chr16:59436345-59436609	HepG2	liver:	n/a	chr16:59436471-59436484 chr16:59436473-59436482 chr16:59436473-59436482 chr16:59436473-59436482 chr16:59436473-59436484 chr16:59436471-59436484 chr16:59436473-59436482 chr16:59436471-59436482
16	CEBPB	chr16:59440678-59440883	HepG2	liver:	n/a	chr16:59440793-59440804
17	CEBPB	chr16:59286963-59287163	HepG2	liver:	n/a	chr16:59287029-59287040 chr16:59286987-59286998 chr16:59287028-59287041
18	CEBPB	chr16:59302805-59302820	A549	lung:	n/a	n/a
19	CEBPB	chr16:59419976-59420242	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr16:59404624-59405081	A549	lung:	n/a	n/a
21	CEBPB	chr16:59445890-59446220	A549	lung:	n/a	chr16:59446020-59446033
22	CEBPB	chr16:59335279-59335479	A549	lung:	n/a	chr16:59335307-59335320 chr16:59335307-59335318 chr16:59335308-59335319
23	CEBPB	chr16:59402619-59402802	K562	blood:	n/a	chr16:59402685-59402696
24	CEBPB	chr16:59402371-59402843	HepG2	liver:	n/a	chr16:59402685-59402696
25	CEBPB	chr16:59335894-59335951	A549	lung:	n/a	chr16:59335906-59335919 chr16:59335908-59335919 chr16:59335906-59335917 chr16:59335906-59335919
26	CEBPB	chr16:59361836-59362142	HepG2	liver:	n/a	n/a
27	CEBPB	chr16:59393572-59393715	A549	lung:	n/a	n/a
28	CEBPB	chr16:59401576-59401860	HepG2	liver:	n/a	n/a
29	CEBPB	chr16:59346843-59347001	IMR90	lung:	n/a	chr16:59346912-59346923 chr16:59346912-59346925
30	CEBPB	chr16:59358171-59358977	A549	lung:	n/a	n/a
31	CEBPB	chr16:59337897-59338084	A549	lung:	n/a	chr16:59337941-59337958
32	CEBPB	chr16:59390473-59391088	K562	blood:	n/a	n/a
33	CEBPB	chr16:59402542-59402845	H1-hESC	embryonic stem cell:	n/a	chr16:59402685-59402696
34	CEBPB	chr16:59440743-59440844	IMR90	lung:	n/a	chr16:59440793-59440804
35	CEBPB	chr16:59402515-59402860	K562	blood:	n/a	chr16:59402685-59402696
36	CEBPB	chr16:59419851-59420302	IMR90	lung:	n/a	n/a
37	CEBPB	chr16:59286956-59286957	A549	lung:	n/a	n/a
38	CEBPB	chr16:59326074-59326099	K562	blood:	n/a	n/a
39	CEBPB	chr16:59335816-59336016	HepG2	liver:	n/a	chr16:59335906-59335919 chr16:59335908-59335919 chr16:59335906-59335917 chr16:59335906-59335919
40	CEBPB	chr16:59358225-59358738	A549	lung:	n/a	n/a
41	CEBPB	chr16:59373805-59374194	H1-hESC	embryonic stem cell:	n/a	n/a
42	CEBPB	chr16:59402529-59402839	K562	blood:	n/a	chr16:59402685-59402696
43	CEBPB	chr16:59335175-59335471	HepG2	liver:	n/a	chr16:59335307-59335320 chr16:59335307-59335318 chr16:59335308-59335319
44	CEBPB	chr16:59402408-59402793	A549	lung:	n/a	chr16:59402685-59402696
45	CEBPB	chr16:59401546-59401807	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr16:59390541-59391028	K562	blood:	n/a	n/a
47	CEBPB	chr16:59445863-59446338	A549	lung:	n/a	chr16:59446020-59446033
48	CEBPB	chr16:59346742-59347078	HepG2	liver:	n/a	chr16:59346912-59346923 chr16:59346912-59346925
49	CEBPD	chr16:59390521-59391146	K562	blood:	n/a	n/a
50	CEBPD	chr16:59390562-59391044	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:59390195-59390245	PrEC	prostate:	n/a
2	chr16:59390195-59390245	HL-60	blood:	n/a
3	chr16:59390195-59390245	CMK	blood:	n/a
4	chr16:59363443-59363493	U87	brain:	n/a
5	chr16:59390195-59390245	SK-N-MC	brain:	n/a
6	chr16:59390195-59390245	ovcar-3	ovarian:	n/a
7	chr16:59363443-59363493	SK-N-SH	brain:	n/a
8	chr16:59363443-59363493	MCF-7	breast:	n/a
9	chr16:59363443-59363493	HMEC	breast:	n/a
10	chr16:59363443-59363493	Hela-S3	cervix:	n/a
11	chr16:59363443-59363493	AG10803	skin:	n/a
12	chr16:59390195-59390245	U87	brain:	n/a
13	chr16:59363443-59363493	SK-N-MC	brain:	n/a
14	chr16:59390195-59390245	HAEpiC	amniotic membrane:	n/a
15	chr16:59363443-59363493	SAEC	small airway:	n/a
16	chr16:59363443-59363493	HIPEpiC	eye:	n/a
17	chr16:59390195-59390245	Hepatocyte	liver:	n/a
18	chr16:59363443-59363493	ECC-1	luminal epithelium:	n/a
19	chr16:59363443-59363493	AG04450	lung:	fetal
20	chr16:59363443-59363493	CMK	blood:	n/a
21	chr16:59363443-59363493	NHBE	bronchial:	n/a
22	chr16:59363443-59363493	GM12892	blood:	n/a
23	chr16:59390195-59390245	ProgFib	skin:	n/a
24	chr16:59390195-59390245	GM12892	blood:	n/a
25	chr16:59390195-59390245	HCM	heart:	n/a
26	chr16:59390195-59390245	NB4	blood:	n/a
27	chr16:59363443-59363493	ovcar-3	ovarian:	n/a
28	chr16:59363443-59363493	SK-N-SH_RA	brain:	n/a
29	chr16:59363443-59363493	HCF	heart:	n/a
30	chr16:59390195-59390245	HRPEpiC	eye:	n/a
31	chr16:59363443-59363493	AG09319	gingival:	n/a
32	chr16:59363443-59363493	SKMC	muscle:	n/a
33	chr16:59363443-59363493	HNPCEpiC	eye:	n/a
34	chr16:59363443-59363493	BJ	skin:	n/a
35	chr16:59363443-59363493	H1-hESC	embryonic stem cell:	embryo
36	chr16:59390195-59390245	NHDF-neo	bronchial:	n/a
37	chr16:59363443-59363493	NHDF-neo	bronchial:	n/a
38	chr16:59390195-59390245	PANC-1	pancreas:	n/a
39	chr16:59363443-59363493	HPAEpiC	pulmonary alveolar:	n/a
40	chr16:59363443-59363493	AoSMC	blood vessel:	n/a
41	chr16:59363443-59363493	NH-A	brain:	n/a
42	chr16:59390195-59390245	A549	lung:	n/a
43	chr16:59363443-59363493	NT2-D1	testis:	n/a
44	chr16:59363443-59363493	HRPEpiC	eye:	n/a
45	chr16:59363443-59363493	HRCEpiC	kidney:	n/a
46	chr16:59390195-59390245	HCT-116	colon:	n/a
47	chr16:59363443-59363493	K562	blood:	n/a
48	chr16:59390195-59390245	HNPCEpiC	eye:	n/a
49	chr16:59390195-59390245	NHBE	bronchial:	n/a
50	chr16:59390195-59390245	BJ	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr16:59388705..59390354-chr16:59392227..59393861,2	K562	blood:
2	chr16:59445008..59446636-chr16:59454260..59456592,2	K562	blood:
3	chr16:59390555..59392761-chr16:59393637..59395380,2	K562	blood:
4	chr16:59390555..59392761-chr16:59393637..59395380,2	K562	blood:
5	chr16:59388705..59390354-chr16:59392227..59393861,2	K562	blood:
6	chr16:59445008..59446636-chr16:59454260..59456592,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-105C20.2.1-2	chr16:59436484-59436576	XLOC_011971
2	lnc-RP11-105C20.2.1-2	chr16:59438650-59438797	XLOC_011971
3	lnc-RP11-105C20.2.1-2	chr16:59445379-59445573	XLOC_011971

Variant related genes	Relation type
ENSG00000238601	TF binding region
ENSG00000238601	CpG island

Extended variants
information (count: 3627 )
Associated
traits (count: 75 )

Variant overlapped rSNPs/rCNVs (count:3627 , 50 per page) page: 1 2 3 4 5 6 7 ... 73

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs182763995	chr16:59282984-59282985	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs540196537	chr16:59282985-59282986	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs551824521	chr16:59282986-59282987	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs371809586	chr16:59282996-59282997	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs369638964	chr16:59283042-59283043	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs560479528	chr16:59283065-59283066	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs147372545	chr16:59283118-59283119	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs137993466	chr16:59283125-59283126	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs559693605	chr16:59283129-59283130	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs189017695	chr16:59283143-59283144	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs149394631	chr16:59283192-59283193	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs549549028	chr16:59283197-59283198	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs571224355	chr16:59283238-59283239	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs538497898	chr16:59283250-59283251	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs78616055	chr16:59283278-59283279	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs74530430	chr16:59283282-59283283	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs535866036	chr16:59283290-59283291	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs554675064	chr16:59283317-59283318	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs11402216	chr16:59291429-59291430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs201828233	chr16:59291430-59291431	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs543213961	chr16:59291434-59291435	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs564887895	chr16:59291442-59291443	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs532322474	chr16:59291482-59291483	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs189642758	chr16:59291488-59291489	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs144963552	chr16:59291505-59291506	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs181575892	chr16:59291508-59291509	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs529747739	chr16:59291512-59291513	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs147824771	chr16:59291557-59291558	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs569790536	chr16:59291599-59291600	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs537097634	chr16:59291601-59291602	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550407601	chr16:59291684-59291685	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs571791581	chr16:59291705-59291706	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs28572258	chr16:59291762-59291763	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs545316385	chr16:59291772-59291773	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs572684524	chr16:59291792-59291793	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs186229318	chr16:59291841-59291842	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs139710857	chr16:59291862-59291863	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs189761142	chr16:59291878-59291879	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs576135123	chr16:59291879-59291880	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs573893043	chr16:59291901-59291902	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs547247280	chr16:59291978-59291979	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs537524619	chr16:59292044-59292045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs4426343	chr16:59292131-59292132	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs142678950	chr16:59292133-59292134	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs576991514	chr16:59292153-59292154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs2897522	chr16:59292161-59292162	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs2406767	chr16:59292190-59292191	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs559722308	chr16:59292205-59292206	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs28825491	chr16:59292271-59292272	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs181150469	chr16:59292282-59292283	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:75)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Infertility	21528002	CNVD
Breast cancer	21806811	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Neurodevelopmental disorder	22521361	CNVD
Glioblastoma multiforme	22286061	CNVD
Autism	18414403	CNVD
Breast cancer	20409316	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ovarian cancer	21720365	CNVD
Leiomyosarcoma	16982739	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20972252	CNVD
Invasive breast cancer	20972252	CNVD
Breast cancer	17142309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:317 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:59282200-59283000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
2	chr16:59282200-59283200	Enhancers	iPS-20b Cell Line	embryonic stem cell
3	chr16:59282400-59283000	Enhancers	ES-I3 Cell Line	embryonic stem cell
4	chr16:59282400-59283000	Enhancers	H9 Cell Line	embryonic stem cell
5	chr16:59282400-59283200	Enhancers	H1 Cell Line	embryonic stem cell
6	chr16:59282400-59283200	Enhancers	HUES48 Cell Line	embryonic stem cell
7	chr16:59282400-59283200	Enhancers	HUES6 Cell Line	embryonic stem cell
8	chr16:59282400-59283200	Enhancers	HUES64 Cell Line	embryonic stem cell
9	chr16:59282400-59283200	Enhancers	iPS-18 Cell Line	embryonic stem cell
10	chr16:59282400-59283400	Enhancers	Fetal Muscle Leg	muscle
11	chr16:59282600-59283200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr16:59282800-59283200	Enhancers	iPS-15b Cell Line	embryonic stem cell
13	chr16:59291400-59291600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
14	chr16:59291400-59293000	Enhancers	Primary T cells from cord blood	blood
15	chr16:59291600-59292600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
16	chr16:59291800-59292000	Enhancers	Primary T helper naive cells from peripheral blood	blood
17	chr16:59292000-59294200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
18	chr16:59292200-59294600	Enhancers	Dnd41	blood
19	chr16:59292600-59293200	Enhancers	Primary T helper cells PMA-I stimulated	--
20	chr16:59292600-59293400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
21	chr16:59292600-59293800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr16:59292800-59293000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr16:59292800-59293200	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr16:59292800-59293600	Enhancers	Primary T helper cells fromperipheralblood	blood
25	chr16:59292800-59294600	Enhancers	Primary hematopoietic stem cells	blood
26	chr16:59292800-59294600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr16:59293000-59293200	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr16:59293000-59293800	Flanking Active TSS	Primary T cells from cord blood	blood
29	chr16:59293000-59294200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr16:59293000-59294600	Enhancers	Primary hematopoietic stem cells short term culture	blood
31	chr16:59293200-59293400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr16:59293200-59293600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr16:59293200-59293600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
34	chr16:59293200-59293600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
35	chr16:59293200-59293600	Active TSS	Primary T killer naive cells fromperipheralblood	blood
36	chr16:59293200-59293600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
37	chr16:59293200-59294600	Enhancers	Fetal Thymus	thymus
38	chr16:59293200-59294600	Enhancers	HSMM	muscle
39	chr16:59293200-59294600	Enhancers	HSMMtube	muscle
40	chr16:59293400-59293800	Active TSS	Primary T helper naive cells fromperipheralblood	blood
41	chr16:59293400-59293800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
42	chr16:59293600-59293800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
43	chr16:59293600-59294600	Enhancers	Primary monocytes fromperipheralblood	blood
44	chr16:59293600-59294600	Weak transcription	Primary T helper cells fromperipheralblood	blood
45	chr16:59293600-59294600	Enhancers	Monocytes-CD14+_RO01746	blood
46	chr16:59293600-59295200	Enhancers	Primary T helper cells PMA-I stimulated	--
47	chr16:59293800-59294200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
48	chr16:59293800-59294600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
49	chr16:59293800-59295200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
50	chr16:59293800-59295400	Enhancers	Primary T killer naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links